Search Results 371-380 of 16047 for pharmacogenetics

  1. Exploring Mechanisms of Action and Resistance of Therapeutic Agents in Patients with B-cell Malignancies - Mayo Clinic

    This study is being performed to understand the causes of drug resistance and to improve the treatment options for patients diagnosed with B-cell cancers. We ...

  2. A Study to Evaluate Ramucirumab Plus Trifluridine/Tipiracil to Treat Patients with Previously-treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma - Mayo Clinic

    The purpose of this study is to compare, in a non-inferiority fashion, the progression-free survival (PFS) in patients with metastatic refractory gastric/ ...

  3. Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer, TraPPer Study - Mayo Clinic

    This phase II trial tests how well pertuzumab, trastuzumab, hyaluronidase-zzxf and enzalutamide works in treating patients with castration-resistant prostate ...

  4. Evaluation of Immunophenotype Signatures in Hypereosinophilia-Associated Disorders - Mayo Clinic

    The purpose of this study is to characterize the immunophenotype of individuals with hypereosinophilia-associated cardiovascular, gastrointestinal, hematologic, ...

  5. Graduate Outcomes - Meet Our Students - Medical Scientist Training Program (M.D.-Ph.D.) - Mayo Clinic College of Medicine & Science

    Graduate outcome information for the M.D.-Ph.D. program in Mayo Clinic Graduate School of Biomedical Sciences.

  6. Drugs and Supplements that Start with V - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “V” to learn about drug side effects, proper use and ...

  7. Pasireotide (subcutaneous route, intramuscular route) - Mayo Clinic

    Pasireotide injection is also used for the treatment of acromegaly (a growth hormone disorder) in patients who cannot be treated with surgery. Signifor® is ...

  8. Daunorubicin Hydrochloride, Cytarabine, and Nilotinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia - Mayo Clinic

    This phase II trial studies how well daunorubicin hydrochloride, cytarabine, and nilotinib work in treating patients newly diagnosed with acute myeloid leukemia ...

  9. Dextromethorphan and quinidine (oral route) - Mayo Clinic

    Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding. Drug Interactions. Although certain medicines ...

  10. Drug Discovery for Parkinson's Disease - Neurobiology of Parkinson's Disease Laboratory - Mayo Clinic Research

    Mayo Clinic's Neurobiology of Parkinson's Disease Lab finds molecules with aggregation-prevention properties that represent potential disease-modifying ...